{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6v1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10104","date":"2024-11-07T17:00:00.000Z","role":"Approver"},{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10104","date":"2024-11-07T13:31:42.460Z","role":"Publisher"}],"curationReasons":{"id":"cg:RecurationNewEvidence"},"evidence":[{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:0a420caf-90df-45ee-b9ba-1e126cb8b986","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:b6f0d711-1051-44c7-a7d9-b49c80cbf477","type":"Finding","demonstrates":{"id":"cg:GeneExpressionA"},"dc:description":"From GTEx bulk tissue expression SLC2A10 is normally expressed in the aorta","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/23715323","type":"dc:BibliographicResource","dc:abstract":"Genome-wide association studies have identified thousands of loci for common diseases, but, for the majority of these, the mechanisms underlying disease susceptibility remain unknown. Most associated variants are not correlated with protein-coding changes, suggesting that polymorphisms in regulatory regions probably contribute to many disease phenotypes. Here we describe the Genotype-Tissue Expression (GTEx) project, which will establish a resource database and associated tissue bank for the scientific community to study the relationship between genetic variation and gene expression in human tissues.","dc:creator":"GTEx Consortium","dc:date":"2013","dc:title":"The Genotype-Tissue Expression (GTEx) project."},"rdfs:label":"GTEx bulk tissue expression "}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"cggv:aaf37346-7aaa-42bc-91d2-9c9ea2ae8d45","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:bf57a660-a9f5-4e81-8183-150abde1053c","type":"Finding","demonstrates":{"id":"cg:BiochemicalFunctionB"},"dc:description":"A number of hypotheses were put forth in the article to connect the molecular function of GLUT10 to the pathogenesis of Arterial Tortuosity Syndrome (ATS). One hypothesis is that the syndromic features of the disease may be due to impaired vitamin C cellular compartmentalization given GLUT10's role in transporting DHA, an oxidized version of vitamin C. Another hypothesis is that GLUT10 disfunction may lead to an increase in ROS and oxidative stress causing ECM fragmentation and disorganization. Finally, it is likely that ATS involves defective TGF-B signaling, as observed from ATS patient fibroblasts.  ","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/31621376","type":"dc:BibliographicResource","dc:creator":"Boel A","dc:date":"2021","dc:title":"Arterial Tortuosity Syndrome: An Ascorbate Compartmentalization Disorder?"},"rdfs:label":"Biochemical function of SLC2A10"}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:9e95cde7-392a-4164-a93e-0a1b17b0676c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:472708df-2ed7-4422-968b-70a33eb0e4af","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"The double knock out model failed to recapitulate a number of the phenotypes observed in ATS. The authors found that double knock out mice exhibited mild decreases in diameter in the descending aorta. Additionally, double knock out mice exhibited evidence of compromised extracellular matrix formation including patches of increased collagen deposition and collagen fiber diameter alterations in DK. A defective extracellular matrix has ben demonstrated in the fibroblasts of ATS patients, though the double knock out model did not demonstrate features such as arterial tortuosity or aortic aneurysm. ","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/32307537","type":"dc:BibliographicResource","dc:abstract":"Arterial tortuosity syndrome (ATS) is a recessively inherited connective tissue disorder, mainly characterized by tortuosity and aneurysm formation of the major arteries. ATS is caused by loss-of-function mutations in SLC2A10, encoding the facilitative glucose transporter GLUT10. Former studies implicated GLUT10 in the transport of dehydroascorbic acid, the oxidized form of ascorbic acid (AA). Mouse models carrying homozygous Slc2a10 missense mutations did not recapitulate the human phenotype. Since mice, in contrast to humans, are able to intracellularly synthesize AA, we generated a novel ATS mouse model, deficient for Slc2a10 as well as Gulo, which encodes for L-gulonolactone oxidase, an enzyme catalyzing the final step in AA biosynthesis in mouse. Gulo;Slc2a10 double knock-out mice showed mild phenotypic anomalies, which were absent in single knock-out controls. While Gulo;Slc2a10 double knock-out mice did not fully phenocopy human ATS, histological and immunocytochemical analysis revealed compromised extracellular matrix formation. Transforming growth factor beta signaling remained unaltered, while mitochondrial function was compromised in smooth muscle cells derived from Gulo;Slc2a10 double knock-out mice. Altogether, our data add evidence that ATS is an ascorbate compartmentalization disorder, but additional factors underlying the observed phenotype in humans remain to be determined.","dc:creator":"Boel A","dc:date":"2020","dc:title":"Slc2a10 knock-out mice deficient in ascorbic acid synthesis recapitulate aspects of arterial tortuosity syndrome and display mitochondrial respiration defects."},"rdfs:label":"Boel et al. SLC2A10 KO mice "}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5,"dc:description":"Downscored to .5 points given the incomplete recapitulation in single and double knock out mouse models. "}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1.5},{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:2186ae96-c906-49c9-adc2-bced9020012e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2186ae96-c906-49c9-adc2-bced9020012e","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":3,"allele":{"id":"cggv:631b0864-e45e-4c5a-9599-bebd43ce0bae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.685C>T (p.Arg229Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347762"}},"phenotypeFreeText":"Downslanting palpebral fissures, Tortuosity of carotid arteries, diameter size of aneurysm (21.8mm)","phenotypes":["obo:HP_0006687","obo:HP_0002616","obo:HP_0001166","obo:HP_0000973"],"sex":"Female","variant":{"id":"cggv:37436bad-1809-4d55-a11e-289169a2709e_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:631b0864-e45e-4c5a-9599-bebd43ce0bae"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/29323665","type":"dc:BibliographicResource","dc:abstract":"We delineate the clinical spectrum and describe the histology in arterial tortuosity syndrome (ATS), a rare connective tissue disorder characterized by tortuosity of the large and medium-sized arteries, caused by mutations in SLC2A10.","dc:creator":"Beyens A","dc:date":"2018","dc:title":"Arterial tortuosity syndrome: 40 new families and literature review."}},"rdfs:label":"Beyens et al. F8"},{"id":"cggv:37436bad-1809-4d55-a11e-289169a2709e","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:37436bad-1809-4d55-a11e-289169a2709e_variant_evidence_item"}],"strengthScore":1,"dc:description":"Variant has a popmax allele frequency of 0.00002153 based upon the European (Non-Finnish) population. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:fd805a01-444d-426f-b134-ab22573d5a13_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:fd805a01-444d-426f-b134-ab22573d5a13","type":"Proband","allele":{"id":"cggv:3368e368-1a5b-48e7-90da-3d66aaa3fdb2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.727C>A (p.Gln243Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA409267924"}},"phenotypeFreeText":"Epicanthal folds, Beaked nose, Micrognathia, Velvety texture, Thin skin, Hyperextensible skin, Pectus deformity, Joint laxity, Brain, pulmonary arteries touristy, Aortic aneurysm '(32mm (Z-score 7,22)), stenosis of IVC, treatment of surgery for aneurysm, inguinal hernia","phenotypes":["obo:HP_0002616","obo:HP_0000276","obo:HP_0001609","obo:HP_0006687"],"sex":"Male","variant":{"id":"cggv:af89d924-aeb1-41f6-9398-b25cb6925a9c_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:3368e368-1a5b-48e7-90da-3d66aaa3fdb2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29323665"},"rdfs:label":"F38"},{"id":"cggv:af89d924-aeb1-41f6-9398-b25cb6925a9c","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:af89d924-aeb1-41f6-9398-b25cb6925a9c_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Variant has a popmax allele frequency of 2.800e-7 based upon the European (Non-Finnish) population"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:6ccc377c-2ea7-4952-ad15-86b5bf916b4c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:6ccc377c-2ea7-4952-ad15-86b5bf916b4c","type":"Proband","allele":{"id":"cggv:28a0d890-018b-48e1-9ce9-610f96a22ab1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.737G>A (p.Gly246Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347785"}},"phenotypeFreeText":"Pulmonary hypertension, Oligohydramnios, Blepharophimosis, Downslanting palpebral fissures, Micrognathia, velvety skin, Hyperextensible skin, Pectus deformity, Joint laxity, size of aneurysm: 29mm (28 mm at 5y8m Z-score is 5,15)- underwent surgical intervention, subclavian stenosis ","phenotypes":["obo:HP_0004415","obo:HP_0002616","obo:HP_0001511","obo:HP_0006687","obo:HP_0000545"],"sex":"Female","variant":{"id":"cggv:822c8261-62d0-493f-8333-b23e46eadc76_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:28a0d890-018b-48e1-9ce9-610f96a22ab1"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29323665"},"rdfs:label":"F24"},{"id":"cggv:822c8261-62d0-493f-8333-b23e46eadc76","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:822c8261-62d0-493f-8333-b23e46eadc76_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Variant has a popmax filtering allele frequency of 0.00001425 based upon the South Asian population in gnomAD 4.0"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:87672ea1-fdaf-4785-a3e4-4708c0c7260d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:87672ea1-fdaf-4785-a3e4-4708c0c7260d","type":"Proband","allele":{"id":"cggv:149cc795-7c78-421e-b15b-c0b96cd5f7ea","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.756C>A (p.Cys252Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347710"}},"phenotypeFreeText":"Lengthening and tortuosity of the aorta, carotid arteries, subclavian arteries, brachiocephalic artery, pulmonary arteries, mesenteric arteries, renal arteries, and internal and external iliac arteries. Displacement of stomach, bilateral hip dislocation, elongated face, micrognathia, long philtrum, sagging cheeks, down-slanting palpebral fissures, beaked nose, and low set ears","phenotypes":"obo:HP_0005116","sex":"Female","variant":{"id":"cggv:8822ab71-69b3-4bfe-a987-4a016aa91919_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:149cc795-7c78-421e-b15b-c0b96cd5f7ea"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/18818946","type":"dc:BibliographicResource","dc:abstract":"Arterial tortuosity syndrome (ATS) is a rare autosomal recessive disorder in which patients display tortuosity of arteries in addition to hyperextensible skin, joint laxity, and other connective tissue features. This syndrome is caused by mutations in the SLC2A10 gene. In this article we describe an ATS girl of Kurdish origin who, in addition to arterial tortuosity and connective tissue features, displays stomach displacement within the thorax and bilateral hip dislocation. Clinical details of this patient have been reported previously. Sequencing of the SLC2A10 gene identified a novel homozygous non-sense c.756C>A mutation in this patient's DNA. This mutation in the SLC2A10 gene replaces a cysteine encoding codon with a stop signal. This is believed to cause a premature truncation of GLUT10 protein in this patient. We conclude that patients of Kurdish origin who display arterial tortuosity associated with skin hyperextensibility, joint hypermobility, and characteristic facial features may carry mutations in the SLC2A10 gene.","dc:creator":"Zaidi SH","dc:date":"2009","dc:title":"A novel non-sense mutation in the SLC2A10 gene of an arterial tortuosity syndrome patient of Kurdish origin."}},"rdfs:label":"Zaidi et al. Proband"},{"id":"cggv:8822ab71-69b3-4bfe-a987-4a016aa91919","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:8822ab71-69b3-4bfe-a987-4a016aa91919_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscored due to homozygosity. Variant absent from gnomad. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:2fc9637c-a28e-418b-98bf-1700932b42c3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:2fc9637c-a28e-418b-98bf-1700932b42c3","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":30,"allele":[{"id":"cggv:1398f26d-362b-4027-8d32-2a51632546ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.1309G>A (p.Glu437Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347770"}},{"id":"cggv:d7ca455e-0926-4e5c-9f4e-130c95d1e9ac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000020.11:g.46727466_46729787del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347792"}}],"phenotypeFreeText":"Beaked nose, aortic aneurysm originally 38 mm)with rapid progression to 49 mm (aortic root, z-score 7.5) in conjunction with an ascending aortic aneurysm of 55 mm.","phenotypes":["obo:HP_0000545","obo:HP_0006687","obo:HP_0000563","obo:HP_0007495","obo:HP_0000023","obo:HP_0000276","obo:HP_0002616"],"sex":"Male","variant":[{"id":"cggv:99ef2114-e54e-40bb-b3fe-c209a5a5984d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1398f26d-362b-4027-8d32-2a51632546ed"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/17935213","type":"dc:BibliographicResource","dc:abstract":"Arterial tortuosity syndrome (ATS) is a rare autosomal recessive connective tissue disease, characterized by widespread arterial involvement with elongation, tortuosity, and aneurysms of the large and middle-sized arteries. Recently, SLC2A10 mutations were identified in this condition. This gene encodes the glucose transporter GLUT10 and was previously suggested as a candidate gene for diabetes mellitus type 2. A total of 12 newly identified ATS families with 16 affected individuals were clinically and molecularly characterized. In addition, extensive cardiovascular imaging and glucose tolerance tests were performed in both patients and heterozygous carriers. All 16 patients harbor biallelic SLC2A10 mutations of which nine are novel (six missense, three truncating mutations, including a large deletion). Haplotype analysis suggests founder effects for all five recurrent mutations. Remarkably, patients were significantly older than those previously reported in the literature (P=0.04). Only one affected relative died, most likely of an unrelated cause. Although the natural history of ATS in this series was less severe than previously reported, it does indicate a risk for ischemic events. Two patients initially presented with stroke, respectively at age 8 months and 23 years. Tortuosity of the aorta or large arteries was invariably present. Two adult probands (aged 23 and 35 years) had aortic root dilation, seven patients had localized arterial stenoses, and five had long stenotic stretches of the aorta. Heterozygous carriers did not show any vascular anomalies. Glucose metabolism was normal in six patients and eight heterozygous individuals of five families. As such, overt diabetes is not related to SLC2A10 mutations associated with ATS.","dc:creator":"Callewaert BL","dc:date":"2008","dc:title":"Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families."}},{"id":"cggv:2bd0fdbd-7a59-4ec4-bd03-55efd16556ab_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d7ca455e-0926-4e5c-9f4e-130c95d1e9ac"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17935213"}],"rdfs:label":"Callewaert et al. E:II-1"},{"id":"cggv:99ef2114-e54e-40bb-b3fe-c209a5a5984d","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:99ef2114-e54e-40bb-b3fe-c209a5a5984d_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Variant has a popmax allele frequency of 0.00001567 based upon the European (Non-Finnish) population. "},{"id":"cggv:2bd0fdbd-7a59-4ec4-bd03-55efd16556ab","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:2bd0fdbd-7a59-4ec4-bd03-55efd16556ab_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Variant is absent from gnomAD v4.0."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:99239845-5160-4284-9e6a-479d56a00ff7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:99239845-5160-4284-9e6a-479d56a00ff7","type":"Proband","ageType":"AgeAtReport","ageUnit":"Months","ageValue":1,"allele":[{"id":"cggv:a53a346c-e058-468c-a43d-b2782586fbfd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.394C>T (p.Arg132Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340267"}},{"id":"cggv:a7cdf249-744a-45d0-b830-dd69269520c2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.254T>C (p.Leu85Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9891940"}}],"phenotypeFreeText":"Long Philtrum, 60mm aortic aneurysm at diagnosis required surgical intervention, aortic stenosis, ","phenotypes":["obo:HP_0002616","obo:HP_0001680","obo:HP_0006687"],"sex":"Male","variant":[{"id":"cggv:24094d03-12e3-49ff-a3ae-bfe0f89b71fd_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a7cdf249-744a-45d0-b830-dd69269520c2"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29323665"},{"id":"cggv:bb15ecb2-983b-4069-9888-99ca71b65dab_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:a53a346c-e058-468c-a43d-b2782586fbfd"},"alleleOrigin":{"id":"obo:GENO_0000877"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29323665"}],"rdfs:label":"F22 "},{"id":"cggv:bb15ecb2-983b-4069-9888-99ca71b65dab","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:bb15ecb2-983b-4069-9888-99ca71b65dab_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Variant has a popmax filtering allele frequency of 0.00005028 based upon the European (Non-Finnish) population in gnomad 4.0."},{"id":"cggv:24094d03-12e3-49ff-a3ae-bfe0f89b71fd","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:24094d03-12e3-49ff-a3ae-bfe0f89b71fd_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Variant has an allele frequency of 0.00001098 based upon the South Asian population in gnomad 4.0. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:9c7721b3-49b4-4107-a51d-48807769111c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:9c7721b3-49b4-4107-a51d-48807769111c","type":"Proband","allele":[{"id":"cggv:0138b028-b7f5-4646-93a4-a49894b50a4e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.899T>G (p.Leu300Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA9892065"}},{"id":"cggv:55e10a41-1bac-4fb4-ad7f-0dffbaf4e13c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.417T>A (p.Tyr139Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA347716"}}],"phenotypeFreeText":"ATS was suspected when severe tortuosity and elongation of the aorta were detected by a screening echocardiogram. Severe myopia and astigmatism. Normal neurological development without major problems except for the presence of dyslalia.","phenotypes":["obo:HP_0002079","obo:HP_0000494","obo:HP_0001382","obo:HP_0002705","obo:HP_0034273","obo:HP_0011220"],"sex":"Female","variant":[{"id":"cggv:74985ab2-1ace-4104-b8a8-aa60f879ad7d_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:55e10a41-1bac-4fb4-ad7f-0dffbaf4e13c"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/37619836","type":"dc:BibliographicResource","dc:abstract":"Arterial tortuosity syndrome (ATS) is an autosomal recessive connective tissue disease caused by biallelic variants in the SLC2A10 gene (NG_016284.1) and characterised by tortuosity and elongation of the aorta and medium-sized arteries. It is considered an extremely rare disease; only 106 individuals with genetically confirmed ATS have been identified to date. Four cases of ATS from two families are described, contributing to the clinical delineation of this condition. A patient with microcephaly and a complex uropathy and two cases with diaphragmatic hernia are noticed. Regarding the vascular involvement, a predominant supra-aortic involvement stands out and only 1 patient with significant arterial stenoses was described. All presented severe tortuosity of the intracranial arteries. To reduce hemodynamic stress on the arterial wall, beta-adrenergic blocking treatment was prescribed. A not previously described variant (NM_030777.4:c.899T>G (p.Leu300Trp)) was detected in a proband; it has an allegedly deleterious effect in compound heterozygous state with the pathogenic variant c.417T>A (p.Tyr139Ter). The other 3 patients, siblings born to healthy consanguineous parents, had a variant in homozygous state: c.510G>A (p.Trp170Ter).","dc:creator":"Esmel-Vilomara R","dc:date":"2023","dc:title":"Arterial tortuosity syndrome: Phenotypic features and cardiovascular manifestations in 4 newly identified patients."}},{"id":"cggv:8b724653-4032-424e-854c-ddd5582f9cad_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:0138b028-b7f5-4646-93a4-a49894b50a4e"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37619836"}],"rdfs:label":"Esmel-Vilomara proband 2"},{"id":"cggv:74985ab2-1ace-4104-b8a8-aa60f879ad7d","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:74985ab2-1ace-4104-b8a8-aa60f879ad7d_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Variant has a popmax AF of 6.800e-7 based upon the European (Non-Finnish) population in gnomad v4.0. "},{"id":"cggv:8b724653-4032-424e-854c-ddd5582f9cad","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:8b724653-4032-424e-854c-ddd5582f9cad_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Variant has a popmax AF of 0.00003232 based upon the Admixed American population in gnomad v4.0."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:27fa44a2-4ec8-4c06-afb7-92e4dea8fc39_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:27fa44a2-4ec8-4c06-afb7-92e4dea8fc39","type":"Proband","allele":{"id":"cggv:9c388d27-5b0a-471e-849c-9291c3d450d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.484del (p.Trp162GlyfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1017976908"}},"firstTestingMethod":"PCR","phenotypeFreeText":"Velvety skin, thin skin, Macroscopic hematuria,","phenotypes":["obo:HP_0002616","obo:HP_0001166","obo:HP_0000545","obo:HP_0002650"],"sex":"Male","variant":{"id":"cggv:beeed63f-5df2-475f-ab8b-9b7b6ebcdc60_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:9c388d27-5b0a-471e-849c-9291c3d450d2"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/29323665"},"rdfs:label":"F26:II-2"},{"id":"cggv:beeed63f-5df2-475f-ab8b-9b7b6ebcdc60","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:beeed63f-5df2-475f-ab8b-9b7b6ebcdc60_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscored due to consanguinity. Variant has a max AF of 0.00001666 based upon the Admixed American population in gnomad. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:813603ea-8a0d-4b33-8c86-0ecc5d758355_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:813603ea-8a0d-4b33-8c86-0ecc5d758355","type":"Proband","allele":{"id":"cggv:b3cb00db-f13f-40e7-b7eb-16e0148432ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.510G>A (p.Trp170Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340263"}},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"mild aortic root dilation, Brain MRI at 1 year of age detected mild white matter loss and also revealed vascular tortuosity of the vertebrobasilar circulation and the circle of Willis, tortuous and dysplastic appearance of both internal carotid arteries and leptomeningeal collaterals. Aortic root dilation remains stable after 4 years of follow-up.","phenotypes":["obo:HP_0004660","obo:HP_0000252","obo:HP_0000316","obo:HP_0011220","obo:HP_0000028","obo:HP_0000776","obo:HP_0001382","obo:HP_0007112","obo:HP_0000369","obo:HP_0010946","obo:HP_0002705","obo:HP_0000545","obo:HP_0008676"],"sex":"UnknownEthnicity","variant":{"id":"cggv:0c4d9cc6-0ffe-4fd6-bb93-7af5adb92d61_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b3cb00db-f13f-40e7-b7eb-16e0148432ed"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37619836"},"rdfs:label":"Esmel-Vilomara et al. Proband 1"},{"id":"cggv:0c4d9cc6-0ffe-4fd6-bb93-7af5adb92d61","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:0c4d9cc6-0ffe-4fd6-bb93-7af5adb92d61_variant_evidence_item"}],"strengthScore":1,"dc:description":"Downscored due to homozygosity. Variant is absent from gnomAD. "}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:dab47e51-1de7-4e07-bd0c-b1339baf1261_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:dab47e51-1de7-4e07-bd0c-b1339baf1261","type":"Proband","allele":[{"id":"cggv:cfd0786a-0192-4f8f-92d9-76052a716250","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.1334del (p.Gly445GlufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA321816"}},{"id":"cggv:1bcfd4c6-34ee-445e-801e-0e0ca0803455","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_030777.4(SLC2A10):c.1276G>T (p.Gly426Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA324232"}}],"phenotypeFreeText":"Aortic root dilation at age 23years (41 mm, z-score 3.9). Aortic root measurements remained stable in the upper normal range (35 mm) up to the age of 21 years butsubsequently increased to 41 mm in 2 yearsâ€™ time. Stroke, Malar hypoplasia, Joint laxity, Tortuosity of other arteries, MPA aneuryism","phenotypes":["obo:HP_0000023","obo:HP_0000545","obo:HP_0000974","obo:HP_0000973","obo:HP_0000276","obo:HP_0006687"],"sex":"UnknownEthnicity","variant":[{"id":"cggv:83977f76-64e5-496c-8ba7-ce2edf718b58_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1bcfd4c6-34ee-445e-801e-0e0ca0803455"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17935213"},{"id":"cggv:a61b094b-5a37-4c78-ae39-6957e1306eaf_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:cfd0786a-0192-4f8f-92d9-76052a716250"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/17935213"}],"rdfs:label":"Callewaert et al. B:II-2 "},{"id":"cggv:83977f76-64e5-496c-8ba7-ce2edf718b58","type":"obo:SEPIO_0004097","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"cggv:83977f76-64e5-496c-8ba7-ce2edf718b58_variant_evidence_item"}],"strengthScore":0.1,"dc:description":"Variant has a popmax allele frequency of 0.00001994 based upon the European (Non-Finnish) population"},{"id":"cggv:a61b094b-5a37-4c78-ae39-6957e1306eaf","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:a61b094b-5a37-4c78-ae39-6957e1306eaf_variant_evidence_item"}],"strengthScore":1.5,"dc:description":"Variant has a popmax allele frequency of 0.0001959 based upon the European (non-Finnish) population."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":9307,"specifiedBy":"GeneValidityCriteria11","strengthScore":13.5,"subject":{"id":"cggv:74233803-a346-4101-a01c-05917ec083c4","type":"GeneValidityProposition","disease":"obo:MONDO_0008818","gene":"hgnc:13444","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"*SLC2A10* has been reported in association with autosomal recessive arterial tortuosity syndrome (ATS) in at least 106 individuals (Callewaert B, De Paepe A, Coucke P, GeneReviews, 2023). Clinical phenotypes of ATS include aortic tortuosity, tortuosity of large and mid-sized arteries, pulmonary artery stenosis, joint hypermobility, ocular abnormalities, and characteristic facial features. Phenotype severity ranges from neonatal lethality to adults with isolated phenotypes. Aortic aneurysms varied from very slowly progressive to rapid dilation and dissection. 14 variants (missense, nonsense, deletion, and frameshift) reported in 10 probands in 4 publications (PMIDs: 17935213, 18818946, 37619836, 29323665) are included in this curation. The mechanism of pathogenicity is loss of function. This gene-disease association is also supported by experimental evidence including protein expression in the aorta (PMID:23715323) and a mouse model double knock out for both SLC2A10 and Gulo that recapitulated isolated phenotypes of ATS including decreases in diameter in the descending aorta and compromised extracellular matrix formation (PMID:32307537). Finally the curation is supported by the biochemical function of *SLC2A10*, which encodes GLUT10, a glucose transporting protein that transports dehydroascorbic acid (DHA). Phenotypes from variants in *SLC2A10* may be a result of impaired vitamin C cellular compartmentalization, increases in ROS/oxidative stress, and defective TGF-B signaling. In summary, *SLC2A10* is definitively associated with autosomal recessive arterial tortuosity syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. The evidence summary was approved by the Heritable Thoracic Aortic Aneurysm and Dissection subgroup of the Hereditary Cardiovascular Disease Gene Curation Expert Panel on 9/6/2024. ","dc:isVersionOf":{"id":"cggv:80a24753-e6d3-41cb-85ba-85a2eae3ddb6"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}